Content created by Office of Infectious Disease and HIV/AIDS Policy (OIDP)
The Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA) is a 29-member federal advisory committee that provides advice to the Secretary of Health and Human Services through the Assistant Secretary for Health on a range of policy issues related to blood, blood products, and tissues.
Recent Updates:
- Toward the Development of a National Red Blood Cell Antibody Patient Data Exchange (RBCAX): 2023 Interim Report, opens in a new tab
- ACBTSA Recommendations to be Considered at Next Meeting
- Federal Register Notice: Solicitation of Nominations for Appointment to the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA), links to an external website
- U.S. Department of Health and Human Services releases report titled Adequacy of the National Blood Supply Report to Congress, 2020
Meetings
Find details about upcoming and previous ACBTSA meetings.
Recommendations
Read ACBTSA’s recommendations from past meetings.
Subcommittees
Find out about the subcommittees within ACBTSA and what they are responsible for.
Partners
Find out about the agencies, stakeholders, and committees ACBTSA partners with.